S&P 500   3,055.87 (-1.94%)
DOW   26,476.10 (-1.79%)
QQQ   211.66 (-2.23%)
BABA   208.74 (+0.00%)
PRI   117.50 (-2.20%)
BAC   30.63 (+0.00%)
S&P 500   3,055.87 (-1.94%)
DOW   26,476.10 (-1.79%)
QQQ   211.66 (-2.23%)
BABA   208.74 (+0.00%)
PRI   117.50 (-2.20%)
BAC   30.63 (+0.00%)
S&P 500   3,055.87 (-1.94%)
DOW   26,476.10 (-1.79%)
QQQ   211.66 (-2.23%)
BABA   208.74 (+0.00%)
PRI   117.50 (-2.20%)
BAC   30.63 (+0.00%)
S&P 500   3,055.87 (-1.94%)
DOW   26,476.10 (-1.79%)
QQQ   211.66 (-2.23%)
BABA   208.74 (+0.00%)
PRI   117.50 (-2.20%)
BAC   30.63 (+0.00%)
Log in

NASDAQ:SXTC - China SXT Pharmaceuticals Stock Price, Forecast & News

$0.96
+0.06 (+6.67 %)
(As of 02/27/2020 09:34 AM ET)
Today's Range
$0.92
Now: $0.96
$0.99
50-Day Range
$0.74
MA: $0.94
$1.15
52-Week Range
$0.65
Now: $0.96
$9.24
Volume227,180 shs
Average Volume1.91 million shs
Market Capitalization$26.62 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives. China SXT Pharmaceuticals, Inc. was founded in 2005 and is based in Taizhou, China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SXTC
CUSIPN/A
CIKN/A
Phone86-523-8629-8290

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.01 million
Cash Flow$0.08 per share
Book Value$0.49 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$26.62 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter.


China SXT Pharmaceuticals (NASDAQ:SXTC) Frequently Asked Questions

What is China SXT Pharmaceuticals' stock symbol?

China SXT Pharmaceuticals trades on the NASDAQ under the ticker symbol "SXTC."

Has China SXT Pharmaceuticals been receiving favorable news coverage?

Media coverage about SXTC stock has been trending negative on Thursday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. China SXT Pharmaceuticals earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for China SXT Pharmaceuticals.

Are investors shorting China SXT Pharmaceuticals?

China SXT Pharmaceuticals saw a decline in short interest during the month of February. As of February 14th, there was short interest totalling 87,200 shares, a decline of 26.4% from the January 30th total of 118,500 shares. Based on an average daily trading volume, of 1,110,000 shares, the short-interest ratio is currently 0.1 days. Currently, 0.7% of the company's stock are sold short. View China SXT Pharmaceuticals' Current Options Chain.

Who are some of China SXT Pharmaceuticals' key competitors?

What other stocks do shareholders of China SXT Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China SXT Pharmaceuticals investors own include AT&T (T), Verizon Communications (VZ), Gilead Sciences (GILD), HEXO (HEXO), Iconix Brand Group (ICON), Intel (INTC), JD.Com (JD), Ollie's Bargain Outlet (OLLI), Zynerba Pharmaceuticals (ZYNE) and AbbVie (ABBV).

Who are China SXT Pharmaceuticals' key executives?

China SXT Pharmaceuticals' management team includes the folowing people:
  • Mr. Feng Zhou, Chairman & CEO (Age 27)
  • Mr. Yao Shi, Chief Financial Officer (Age 38)
  • Dr. Jingzhen Deng, Chief Scientific Officer & COO (Age 59)
  • Mr. Jun Zheng, Exec. Director (Age 40)

Who are China SXT Pharmaceuticals' major shareholders?

China SXT Pharmaceuticals' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.64%).

Which major investors are buying China SXT Pharmaceuticals stock?

SXTC stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is China SXT Pharmaceuticals' stock price today?

One share of SXTC stock can currently be purchased for approximately $0.96.

How big of a company is China SXT Pharmaceuticals?

China SXT Pharmaceuticals has a market capitalization of $26.62 million and generates $7.01 million in revenue each year. View Additional Information About China SXT Pharmaceuticals.

What is China SXT Pharmaceuticals' official website?

The official website for China SXT Pharmaceuticals is http://www.sxtchina.com/.

How can I contact China SXT Pharmaceuticals?

China SXT Pharmaceuticals' mailing address is 178 TAIDONG ROAD NORTH, TAIZHOU F4, 225300. The company can be reached via phone at 86-523-8629-8290 or via email at [email protected]


MarketBeat Community Rating for China SXT Pharmaceuticals (NASDAQ SXTC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  165
MarketBeat's community ratings are surveys of what our community members think about China SXT Pharmaceuticals and other stocks. Vote "Outperform" if you believe SXTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SXTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel